1.Outcomes of chronic hepatitis B infection in Oriental patients with rheumatic diseases.
Bernard Y H THONG ; Ee Tzun KOH ; Hiok Hee CHNG ; Wan Cheng CHOW
Annals of the Academy of Medicine, Singapore 2007;36(2):100-105
INTRODUCTIONThe aim of this study was to ascertain the outcomes of chronic hepatitis B (CHB) infection following immunosuppressive therapy in 38 consecutive oriental patients with systemic rheumatic diseases.
MATERIALS AND METHODSThis is a retrospective consecutive, non-comparative study.
RESULTSThe majority of patients were female (26, 68.4%), predominantly Chinese (92.1%), with a mean age 54 +/- 14 years (range, 16 to 87). The mean duration of rheumatic disease was 9 +/- 11 years (range, 0.1 to 48), with rheumatoid arthritis (52.6%) and systemic lupus erythematosus (23.7%) being the most common. The mean duration of CHB infection was 6 +/- 5 years (range, 0.1 to 17), with the majority diagnosed during pre-methotrexate screening (50.0%) and asymptomatic transaminitis following initiation of immunosuppressive therapy (23.7%). Upon diagnosis of rheumatic disease, all patients had normal alanine aminotransferase (ALT). Of these, 18.2% were positive for hepatitis B e antigen (HBeAg) and 78.1% were positive for anti- HBe antibody. Twenty (52.6%) developed ALT elevation, which was more than twice the upper limit of normal in 12 patients. ALT normalised spontaneously in 12 patients without hepatic decompensation or change in therapy. Seven (18.4%) patients received lamivudine for 18 +/- 22 months (range, 2 to 61). Two patients developed YMDD mutation subsequently treated with adefovir (1) and adefovir/lamivudine (1). There were 3 (7.9%) hepatitis B virus (HBV)-unrelated deaths [infection (2), genitourinary malignancy (1)], and 1 from HBV-reactivation complicated by septicaemia. None have developed hepatocellular carcinoma.
CONCLUSIONElevated ALT occurred in 52.6% of patients, with only 18.4% requiring anti-viral therapy for HBV reactivation. HBV-related mortality was low. With the appropriate precautionary measures, prednisolone and immunosuppressants (except methotrexate and leflunomide) may be used safely in patients where clinically indicated.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alanine Transaminase ; blood ; Antiviral Agents ; therapeutic use ; Asian Continental Ancestry Group ; Comorbidity ; Female ; Glucocorticoids ; therapeutic use ; Hepatitis B, Chronic ; epidemiology ; Humans ; Immunosuppressive Agents ; therapeutic use ; Lamivudine ; therapeutic use ; Lupus Erythematosus, Systemic ; drug therapy ; Male ; Middle Aged ; Prednisolone ; therapeutic use ; Retrospective Studies ; Rheumatic Diseases ; epidemiology ; Treatment Outcome ; Virus Activation
2.Epidemiology and Clinical Evolution of Liver Cirrhosis in Singapore.
Pik Eu CHANG ; Guan Wee WONG ; James Wq LI ; Hock Foong LUI ; Wan Cheng CHOW ; Chee Kiat TAN
Annals of the Academy of Medicine, Singapore 2015;44(6):218-225
INTRODUCTIONLiver cirrhosis is a common cause of morbidity and mortality and an important burden on the healthcare system. There is limited literature on liver cirrhosis in Singapore. We aimed to describe the epidemiology and clinical characteristics of cirrhotic patients seen in an ambulatory setting in a tertiary referral centre.
MATERIALS AND METHODSThis is a retrospective observational cohort study of cirrhotic patients attending the ambulatory clinic of Singapore's largest tertiary hospital over 5 years. Cirrhosis was diagnosed on characteristic radiological features and/or histology. Aetiology of cirrhosis was determined by history, serology, biochemistry and/or histology. Data on decompensation events and death were retrieved from computerised hospital records.
RESULTSThe study included 564 patients with median follow-up of 85 months. Mean age was 60.9 ± 12.5 years with 63.8% males. Main aetiologies of cirrhosis were chronic hepatitis B (CHB) (63.3%), alcohol (11.2%), cryptogenic (9%) and chronic hepatitis C (CHC) (6.9%). CHB was the predominant aetiology in Chinese and Malays whereas alcohol was the main aetiology in Indians. CHC cirrhosis was more common in Malays than other races. Majority had compensated cirrhosis with 76.8%/18.3%/5%; Child-Pugh A/B/C respectively. Decompensation events occurred in 155 patients (27.5%) and 106 of them (18.8%) died. Diagnosis of cirrhosis via surveillance ultrasound was associated with improved 10-year survival. Age at diagnosis, portal vein thrombosis, Child-Pugh class and decompensation within 1 year of diagnosis were independent predictors of mortality.
CONCLUSIONCHB is the primary cause of liver cirrhosis in Singapore. The major aetiologies of cirrhosis vary amongst the different ethnic groups. Cirrhotics with advanced age, portal vein thrombosis, poorer liver function and early decompensation have a higher mortality risk.
Adult ; Aged ; Ambulatory Care ; Female ; Follow-Up Studies ; Humans ; Liver Cirrhosis ; diagnosis ; epidemiology ; etiology ; therapy ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Singapore ; epidemiology
3.Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore.
Pik Eu CHANG ; Juanda Leo HARTONO ; Yee Lin NGAI ; Yock Young DAN ; Kieron Bl LIM ; Wan Cheng CHOW
Singapore medical journal 2019;60(10):532-537
INTRODUCTION:
Despite the widespread use of transient elastography for non-invasive assessment of liver fibrosis, the optimal cut-off liver stiffness measurement (LSM) values remain unclear. This study aimed to validate the optimal cut-off LSM values for significant fibrosis and cirrhosis in patients with chronic liver disease (CLD).
METHODS:
Prospective multicentre data of CLD patients who underwent paired liver biopsy and LSM was analysed to determine the optimal cut-off LSM values for predicting significant fibrosis (METAVIR F ≥ 2) and cirrhosis (METAVIR F4). A high-quality cohort was selected by excluding those with failed LSM and invalid LSM readings.
RESULTS:
Of the 481 patients recruited, 322 fulfilled the pre-defined quality criteria. CLD aetiology was chronic hepatitis B (CHB) in 49%, non-alcoholic steatohepatitis (NASH) in 16% and chronic hepatitis C (CHC) in 12%. Area under the receiver operating characteristic curve for LSM was 0.775 (95% confidence interval [CI] 0.724-0.826) for significant fibrosis and 0.810 (95% CI 0.738-0.882) for cirrhosis. Optimal cut-off LSM values were 9 kPa for significant fibrosis and 13 kPa for cirrhosis in the general cohort. Optimal cut-off LSM values were 9 kPa for significant fibrosis and 12 kPa for cirrhosis for both CHB and CHC, while the corresponding values for NASH were 11 kPa and 15 kPa.
CONCLUSION
Optimal cut-off LSM values should be selected based on disease aetiology. In Singapore, the optimal cut-off LSM values for CHB and CHC are 9 kPa for significant fibrosis and 12 kPa for cirrhosis. Optimal cut-off values for NASH require further validation.
4.Perception of disease, well-being and financial burden by patients with chronic hepatitis B: A self-reported assessment.
Ruojun DING ; Gayathry MORVIL ; Boon Bee George GOH ; Thinesh Lee KRISHNAMOORTHY ; Pei Yuh CHIA ; Hiang Keat TAN ; Victoria Sze Min EKSTROM ; Chang Chuen Mark CHEAH ; Jin Yang Terence TAN ; Pek Siang Edmund TEO ; Pik Eu Jason CHANG ; Chee Kiat TAN ; Xiaohui XIN ; Wan Cheng CHOW ; Rajneesh KUMAR
Annals of the Academy of Medicine, Singapore 2022;51(6):378-380
5.Authors' reply.
Benjy Yi-Min SOH ; Rajneesh KUMAR ; Victoria Sze-Min EKSTROM ; Clement Yi-Hao LIN ; Sobhana D/O THANGARAJU ; Hwee Huang TAN ; Kwai Peng CHAN ; Lina Hui Lin CHOONG ; Diana TEO ; Wan Cheng CHOW
Singapore medical journal 2019;60(6):323-323
Blood Donors
;
Genotype
;
Hepacivirus
;
Humans
;
Interferons
;
Prevalence
6.Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.
Benjy Yi-Min SOH ; Rajneesh KUMAR ; Victoria Sze-Min EKSTROM ; Clement Yi-Hao LIN ; Sobhana THANGARAJU ; Hwee Huang TAN ; Kwai Peng CHAN ; Lina Hui Lin CHOONG ; Diana TEO ; Wan Cheng CHOW
Singapore medical journal 2019;60(1):34-39
INTRODUCTION:
To study the prevalence of hepatitis C virus (HCV) infection in blood donor (BD), haemodialysis (HD) and intravenous drug user (IVDU) populations in Singapore and assess the IL28B polymorphism if HCV positive.
METHODS:
The BD population were healthy volunteers, the HD population were patients who were on haemodialysis for at least six months of follow-up between January 2009 and December 2014. IVDU population was from inmates at halfway houses who consented.
RESULTS:
Between 2011 and 2014, of 161,658 individuals who underwent screening prior to blood donation, 95 (0.059%) were positive for HCV. Of the 42 sera available, common genotypes (GTs) were GT-3 (47.6%) and GT-1 (31.0%). Of 1,575 HD patients, 2.2% were anti-HCV positive. The HCV GT distribution was HCV GT-1 (32.4%), HCV GT-3 (20.5%) and GT-6 (8.8%). 83 halfway house inmates were screened. Of the 47 IVDUs, 36.2% were anti-HCV positive with predominant GT-3 (%). IL28B polymorphism was noted to be CC predominantly 85.3%.
CONCLUSION
Prevalence of HCV infection has decreased in both the BD and HD populations. However, it remains high in the IVDU population. GT-1 remains the most common in the HD population; however, GT-3 infection is now more common among the BD population in Singapore. IL28B - CC is the predominant variant among the HCV-infected individuals in Singapore.
Acute Kidney Injury
;
blood
;
complications
;
Adult
;
Alleles
;
Blood Donors
;
Female
;
Genotype
;
Hepatitis C
;
epidemiology
;
Humans
;
Interleukins
;
genetics
;
Male
;
Middle Aged
;
Polymorphism, Single Nucleotide
;
Prevalence
;
Renal Dialysis
;
Singapore
;
epidemiology
;
Substance Abuse, Intravenous
;
blood
;
epidemiology
;
Young Adult